<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10468296</article-id><article-id pub-id-type="pmc">2363122</article-id><article-id pub-id-type="pii">6690597</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690597</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Halme</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Knuuttila</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vehmas</surname><given-names>T</given-names></name><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Tammilehto</surname><given-names>L</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">3</xref></contrib><contrib contrib-type="author"><name><surname>Salo</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1">4</xref></contrib><contrib contrib-type="author"><name><surname>Mattson</surname><given-names>K</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Medicine, Division of Pulmonary Medicine and Clinical Physiology, and Departments of <label>2</label>Radiology, <label>3</label>Oncology and <label>4</label>Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Helsinki, HYKS, FIN-00029, Finland</aff><aff id="aff5"><label>5</label>Finnish Institute of Occupational Health, Helsinki, 00290, Finland</aff><pub-date pub-type="ppub"><month>08</month><year>1999</year></pub-date><volume>80</volume><issue>11</issue><fpage>1781</fpage><lpage>1785</lpage><history><date date-type="received"><day>22</day><month>07</month><year>1998</year></date><date date-type="accepted"><day>20</day><month>02</month><year>1999</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><kwd-group><kwd>high dose MTX</kwd><kwd>IFN-&#x003b1;</kwd><kwd>IFN-&#x003b3;</kwd><kwd>pleural mesothelioma</kwd></kwd-group></article-meta></front></article>


